Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: A report of Radiation Therapy Oncology Group 83-02

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 5, 1997, Pages 911-914

  Donahue, Bernadine ^a   Scott, Charles B ^b   Nelson, James S ^c   Rotman, Marvin ^d   Murray, Kevin J ^e   Nelson, Diana F ^f   Banker, Franklin L ^g   Earle, John D ^h   Fischbach, Jennifer A ⁱ   Asbell, Sucha O ^j   Gaspar, Laurie E ^k   Markoe, Arnold M ^l   Curran, Walter ^m  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b AMERICAN COLLEGE OF RADIOLOGY   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^g Radiological Associates of Sacramento Medical Group Inc   (United States)

^h MAYO CLINIC   (United States)

ⁱ Latter Day Saints Hospital   (United States)

^j ALBERT EINSTEIN MEDICAL CENTER   (United States)

^k WAYNE STATE UNIVERSITY   (United States)

^l UNIVERSITY OF MIAMI   (United States)

^m THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

more..

Author keywords

Anaplastic astrocytoma; Hyperfractionation; Oligodendroglioma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TREATMENT OUTCOME; TUMOR BIOPSY;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; COMBINED MODALITY THERAPY; GLIOBLASTOMA; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOTHERAPY DOSAGE;

EID: 0030839909     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00126-0     Document Type: Article

References (7)

1. Hart, M. N.; Petito, C. K.; Earle, K. M. Mixed gliomas. Cancer 33:134-140; 1974.
2. Mahaley, M. S.; Mettlin, C.; Natarajan, N. National survey of patterns of care for brain tumor patients. J. Neurosurg. 71:826-836; 1989.
3. Nelson, J. S.; Petito, C. K.; Scott, C. B.; Rotman, M. Asbell, S.O.; Murray, K. J. Glioblastoma with oligodendroglial features (GBM-OL). Report from RTOG trial 83-02. (Abstr.) Lab. Invest. 74:141A; 1996.
4. Peterson, K.; Cairncross, J. G. Oligodendroglioma. Cancer Invest. 14:243-251; 1996.
5. Shaw, E. G.; Scheithauer, B. W.; O'Fallon, J. R. Astrocytomas, oligo-astrocytomas, and oligodendrogliomas: a comparative survival study. J. Neurooncol. 42:342; 1992.
6. Werner-Wasik, M.; Scott, C. B.; Nelson, D. F.; Caspar, L. E.; Murray, K. J.; Fischbach, J. A.; Nelson, J. S.; Weinstein, A. S.; Curran, W. J. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. RTOG study 83-02. Cancer 77:1535-1543; 1996.
7. Winger, M. J.; Macdonald, D. R.; Cairncross, J. C. Supratententorial anaplastic gliomas in adults: the prognostic importance of extent of resection and prior low-grade glioma. J. Neurosurg. 71:487-493; 1989.